The optimum cutoffs for the 3 biomarkers (H-score ≥ 210 for CXCR4+ tumor tissue, CTCs ≥6, and CXCR4+ CTCs ≥7%) were applied to survival analyses by treatment arm. Here, CXCR4 is linked to neoplasm.